National Pharmaceutical Council
The National Pharmaceutical Council is an American health policy research organization that lobbies the U.S. Government to further support medical innovation.
History
NPC was founded in 1953 with support from the nation’s major research-based biopharmaceutical companies.1)
Membership
Members of the NPC include AbbVie, Amgen, Astellas, AstraZeneca, Bayer, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Genentech, Gilead Sciences, Horizon Therapeutics, Johnson & Johnson, Mallinckrodt, Merck, Novartis, Pfizer, Sarepta Therapautics, Spark Therapeutics, Takeda, and UCB.2)
1)
National Pharmaceutical Council | Strategic Alliance Partners. Pharmacy Times. Retrieved April 6, 2022, from https://archive.ph/DX3Hg
2)
Members. National Pharmaceutical Council. Retrieved April 6, 2022, from https://web.archive.org/web/20211102074208/https://www.npcnow.org/about/members